BIOMAT Database Logo BIOMAT Database Logo

IgE and allergen-specific immunotherapy-induced IgG4 recognize similar epitopes of Bet v 1, the major allergen of birch pollen. 2017

N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
Division of Allergology, Paul-Ehrlich-Institut, Langen, Germany.

BACKGROUND Allergen-specific immunotherapy (AIT) with birch pollen generates Bet v 1-specific immunoglobulin (Ig)G4 which blocks IgE-mediated hypersensitivity mechanisms. Whether IgG4 specific for Bet v 1a competes with IgE for identical epitopes or whether novel epitope specificities of IgG4 antibodies are developed is under debate. OBJECTIVE We sought to analyze the epitope specificities of IgE and IgG4 antibodies from sera of patients who received AIT. METHODS 15 sera of patients (13/15 received AIT) with Bet v 1a-specific IgE and IgG4 were analyzed. The structural arrangements of recombinant (r)Bet v 1a and rBet v 1a_11x , modified in five potential epitopes, were analyzed by circular dichroism and nuclear magnetic resonance spectroscopy. IgE binding to Bet v 1 was assessed by ELISA and mediator release assays. Competitive binding of monoclonal antibodies specific for Bet v 1a and serum IgE/IgG4 to rBet v 1a and serum antibody binding to a non-allergenic Bet v 1-type model protein presenting an individual epitope for IgE was analyzed in ELISA and western blot. RESULTS rBet v 1a_11x had a Bet v 1a - similar secondary and tertiary structure. Monomeric dispersion of rBet v 1a_11x was concentration and buffer-dependent. Up to 1500-fold increase in the EC50 for IgE-mediated mediator release induced by rBet v 1a_11x was determined. The reduction of IgE and IgG4 binding to rBet v 1a_11x was comparable in 67% (10/15) of sera. Bet v 1a-specific monoclonal antibodies inhibited binding of serum IgE and IgG4 to 66.1% and 64.9%, respectively. Serum IgE and IgG4 bound specifically to an individual epitope presented by our model protein in 33% (5/15) of sera. CONCLUSIONS Patients receiving AIT develop Bet v 1a-specific IgG4 which competes with IgE for partly identical or largely overlapping epitopes. The similarities of epitopes for IgE and IgG4 might stimulate the development of epitope-specific diagnostics and therapeutics.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D005260 Female Females
D006255 Rhinitis, Allergic, Seasonal Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS. Hay Fever,Pollen Allergy,Pollinosis,Seasonal Allergic Rhinitis,Hayfever,Allergic Rhinitides, Seasonal,Allergic Rhinitis, Seasonal,Allergies, Pollen,Allergy, Pollen,Fever, Hay,Pollen Allergies,Pollinoses,Rhinitides, Seasonal Allergic,Rhinitis, Seasonal Allergic,Seasonal Allergic Rhinitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
February 1995, Journal of immunology (Baltimore, Md. : 1950),
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
The major birch pollen allergen, Bet v 1, shows ribonuclease activity.
January 1996, Planta,
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG1 and IgG4 against the Major Birch Pollen Allergen Bet v 1.
August 2020, International journal of molecular sciences,
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
November 2013, Allergy,
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.
January 1999, International archives of allergy and immunology,
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
The History and Science of the Major Birch Pollen Allergen Bet v 1.
July 2023, Biomolecules,
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
Dynamics Rationalize Proteolytic Susceptibility of the Major Birch Pollen Allergen Bet v 1.
January 2020, Frontiers in molecular biosciences,
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice.
January 2001, International archives of allergy and immunology,
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
High-level expression and purification of the major birch pollen allergen, Bet v 1.
February 1997, Protein expression and purification,
N Groh, and C S von Loetzen, and B Subbarayal, and C Möbs, and L Vogel, and A Hoffmann, and K Fötisch, and A Koutsouridou, and S Randow, and E Völker, and A Seutter von Loetzen, and P Rösch, and S Vieths, and W Pfützner, and B Bohle, and D Schiller
Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE.
February 2013, Immunology and cell biology,
Copied contents to your clipboard!